Correlation
The correlation between TATT and BMRN is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
TATT vs. BMRN
Compare and contrast key facts about Tat Techno (TATT) and BioMarin Pharmaceutical Inc. (BMRN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TATT or BMRN.
Performance
TATT vs. BMRN - Performance Comparison
Loading data...
Key characteristics
TATT:
1.19
BMRN:
-0.63
TATT:
1.86
BMRN:
-0.65
TATT:
1.24
BMRN:
0.90
TATT:
2.75
BMRN:
-0.35
TATT:
7.04
BMRN:
-0.86
TATT:
10.16%
BMRN:
25.48%
TATT:
60.53%
BMRN:
34.94%
TATT:
-97.34%
BMRN:
-90.58%
TATT:
-26.07%
BMRN:
-61.06%
Fundamentals
TATT:
$340.31M
BMRN:
$11.23B
TATT:
$1.03
BMRN:
$2.72
TATT:
26.68
BMRN:
21.53
TATT:
0.00
BMRN:
0.84
TATT:
2.12
BMRN:
3.81
TATT:
2.58
BMRN:
1.94
TATT:
$160.17M
BMRN:
$2.94B
TATT:
$35.90M
BMRN:
$2.32B
TATT:
$14.31M
BMRN:
$738.30M
Returns By Period
In the year-to-date period, TATT achieves a 1.36% return, which is significantly higher than BMRN's -11.65% return. Over the past 10 years, TATT has outperformed BMRN with an annualized return of 17.06%, while BMRN has yielded a comparatively lower -7.31% annualized return.
TATT
1.36%
-8.54%
14.28%
71.31%
63.92%
47.25%
17.06%
BMRN
-11.65%
-8.82%
-12.06%
-22.03%
-8.23%
-11.43%
-7.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TATT vs. BMRN — Risk-Adjusted Performance Rank
TATT
BMRN
TATT vs. BMRN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Tat Techno (TATT) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TATT vs. BMRN - Dividend Comparison
Neither TATT nor BMRN has paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TATT Tat Techno | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.24% | 19.03% | 0.00% | 3.40% |
BMRN BioMarin Pharmaceutical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
TATT vs. BMRN - Drawdown Comparison
The maximum TATT drawdown since its inception was -97.34%, which is greater than BMRN's maximum drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for TATT and BMRN.
Loading data...
Volatility
TATT vs. BMRN - Volatility Comparison
Tat Techno (TATT) has a higher volatility of 22.15% compared to BioMarin Pharmaceutical Inc. (BMRN) at 7.96%. This indicates that TATT's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TATT vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Tat Techno and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TATT vs. BMRN - Profitability Comparison
TATT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Tat Techno reported a gross profit of 9.95M and revenue of 42.14M. Therefore, the gross margin over that period was 23.6%.
BMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported a gross profit of 593.59M and revenue of 745.15M. Therefore, the gross margin over that period was 79.7%.
TATT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Tat Techno reported an operating income of 4.17M and revenue of 42.14M, resulting in an operating margin of 9.9%.
BMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported an operating income of 223.89M and revenue of 745.15M, resulting in an operating margin of 30.1%.
TATT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Tat Techno reported a net income of 3.81M and revenue of 42.14M, resulting in a net margin of 9.1%.
BMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, BioMarin Pharmaceutical Inc. reported a net income of 185.69M and revenue of 745.15M, resulting in a net margin of 24.9%.